Company Description
Molecular Templates (OTC: MTEM) is a publicly traded pharmaceutical preparation manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $191.9K, ranking #7,079 among all listed U.S. companies by market cap.
MTEM stock has declined 100.0% over the past year. Shares last traded at $0.0001.
This page provides a comprehensive overview of MTEM stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Molecular Templates (MTEM) stock last traded at $0.0001. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $191.9K, MTEM is classified as a micro-cap stock with approximately 6.6M shares outstanding.
Latest News
Molecular Templates has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, clinical trial, private placement, conferences. View all MTEM news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Molecular Templates (MTEM) currently stands at 5.8 thousand shares, down 0.8% from the previous reporting period, representing 0.1% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Molecular Templates (MTEM) currently stands at 1.6 days, up 59% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 59% over the past year, indicating either rising short interest or declining trading volume.
MTEM Company Profile & Sector Positioning
Molecular Templates (MTEM) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the OTC.